Your browser doesn't support javascript.
loading
A joint ESTRO and AAPM guideline for development, clinical validation and reporting of artificial intelligence models in radiation therapy.
Hurkmans, Coen; Bibault, Jean-Emmanuel; Brock, Kristy K; van Elmpt, Wouter; Feng, Mary; David Fuller, Clifton; Jereczek-Fossa, Barbara A; Korreman, Stine; Landry, Guillaume; Madesta, Frederic; Mayo, Chuck; McWilliam, Alan; Moura, Filipe; Muren, Ludvig P; El Naqa, Issam; Seuntjens, Jan; Valentini, Vincenzo; Velec, Michael.
Afiliação
  • Hurkmans C; Department of Radiation Oncology, Catharina Hospital, Eindhoven, the Netherlands; Department of Electrical Engineering, Technical University Eindhoven, Eindhoven, the Netherlands. Electronic address: Coen.hurkmans@cze.nl.
  • Bibault JE; Department of Radiation Oncology, Georges Pompidou European Hospital, Paris, France.
  • Brock KK; Departments of Imaging Physics and Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • van Elmpt W; Department of Radiation Oncology (MAASTRO), GROW - School for Oncology and Reproduction, Maastricht University Medical Centre+, Maastricht, the Netherlands.
  • Feng M; University of California San Francisco, San Francisco, CA, USA.
  • David Fuller C; Department of Radiation Oncology, The University of Texas MD Anderson Cancer, Houston, TX.
  • Jereczek-Fossa BA; Dept. of Oncology and Hemato-oncology, University of Milan, Milan, Italy; Dept. of Radiation Oncology, IEO European Institute of Oncology IRCCS, Milan, Italy.
  • Korreman S; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark; Danish Center for Particle Therapy, Aarhus University Hospital, Aarhus, Denmark.
  • Landry G; Department of Radiation Oncology, LMU University Hospital, LMU Munich, Munich, Germany; German Cancer Consortium (DKTK), Partner Site Munich, a Partnership between DKFZ and LMU University Hospital Munich, Germany; Bavarian Cancer Research Center (BZKF), Partner Site Munich, Munich, Germany.
  • Madesta F; Department of Computational Neuroscience, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; Institute for Applied Medical Informatics, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; Center for Biomedical Artificial Intelligence (bAIome), University Medical Center Hamburg
  • Mayo C; Institute for Healthcare Policy and Innovation, University of Michigan, USA.
  • McWilliam A; Division of Cancer Sciences, The University of Manchester, Manchester, UK.
  • Moura F; CrossI&D Lisbon Research Center, Portuguese Red Cross Higher Health School Lisbon, Portugal.
  • Muren LP; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark; Danish Center for Particle Therapy, Aarhus University Hospital, Aarhus, Denmark.
  • El Naqa I; Department of Machine Learning, Moffitt Cancer Center, Tampa, FL 33612, USA.
  • Seuntjens J; Princess Margaret Cancer Centre, Radiation Medicine Program, University Health Network & Departments of Radiation Oncology and Medical Biophysics, University of Toronto, Toronto, Canada.
  • Valentini V; Department of Diagnostic Imaging, Oncological Radiotherapy and Hematology, Fondazione Policlinico Universitario "Agostino Gemelli" IRCCS, Rome, Italy; Università Cattolica del Sacro Cuore, Rome, Italy.
  • Velec M; Radiation Medicine Program, Princess Margaret Cancer Centre and Department of Radiation Oncology, University of Toronto, Toronto, Canada.
Radiother Oncol ; 197: 110345, 2024 Aug.
Article em En | MEDLINE | ID: mdl-38838989
ABSTRACT
BACKGROUND AND

PURPOSE:

Artificial Intelligence (AI) models in radiation therapy are being developed with increasing pace. Despite this, the radiation therapy community has not widely adopted these models in clinical practice. A cohesive guideline on how to develop, report and clinically validate AI algorithms might help bridge this gap. METHODS AND MATERIALS A Delphi process with all co-authors was followed to determine which topics should be addressed in this comprehensive guideline. Separate sections of the guideline, including Statements, were written by subgroups of the authors and discussed with the whole group at several meetings. Statements were formulated and scored as highly recommended or recommended.

RESULTS:

The following topics were found most relevant Decision making, image analysis, volume segmentation, treatment planning, patient specific quality assurance of treatment delivery, adaptive treatment, outcome prediction, training, validation and testing of AI model parameters, model availability for others to verify, model quality assurance/updates and upgrades, ethics. Key references were given together with an outlook on current hurdles and possibilities to overcome these. 19 Statements were formulated.

CONCLUSION:

A cohesive guideline has been written which addresses main topics regarding AI in radiation therapy. It will help to guide development, as well as transparent and consistent reporting and validation of new AI tools and facilitate adoption.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Inteligência Artificial / Técnica Delphi Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Inteligência Artificial / Técnica Delphi Idioma: En Ano de publicação: 2024 Tipo de documento: Article